We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Invesco Markets plc KBW NASDAQ Fintech UCITS A USD (FTEK)

Sell:$59.19 Buy:$59.30 0 Change: $0.60 (1.02%)
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$59.19
Buy:$59.30
Change: $0.60 (1.02%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$59.19
Buy:$59.30
Change: $0.60 (1.02%)
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

REPLICATION

Replication method: Swaps
Rebalancing frequency: Quarterly
Number of holdings: 49
How is collateral used? Unfunded Swap

SECURITIES LENDING

Is stock lending permitted?: No
Is stock currently being lent?: No
Maximum that can be lent: n/a
12 month average % on loan: n/a
12 month return from stock lending: n/a
Gross revenue returned: n/a

COUNTERPARTIES

Issuer: Invesco Markets plc
Investment Manager: n/a
Trustee Northern Trust Fiduciary Services (Ireland) Limited
Custodian: Northern Trust Fiduciary Services (Ireland) Limited
Security Weight
LEMONADE 4.43%
SOFI TECHNOLOGIES INC 3.31%
COINBASE GLOBAL 3.02%
ROBINHOOD MARKETS INC 2.74%
BILL HLDGS INC 2.74%
TOAST INC 2.58%
AFFIRM HLDGS INC 2.52%
LPL FINANCIAL HLDGS INC 2.50%
LENDINGCLUB CORP 2.44%
INTERACTIVE BROKERS GROUP 2.38%

ASSET SPLIT

Annual & interim reports

Before you invest, please make sure you read the documents below

OBJECTIVE

Index: The NASDAQ Biotechnology Index Total Return provides exposure to biotechnology and pharmaceuticals companies (as defined by Industry Classification Benchmark) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements.
Aim: The Invesco KBW NASDAQ Fintech UCITS ETF aims to provide the performance of the KBW...
Read full aim for Invesco Markets plc
Leverage: 100%
Currency hedging: n/a

COSTS

Ongoing Charge (OCF/TER): 0.49%
Management fee: 0.49%
Indicative spread: 0.19%

In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.

Company announcements

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data provided by Broadridge. Some of the data on this page and other related pages is provided to you for your information and is received from the Fund Management Company administering this fund. Hargreaves Lansdown accepts no liability for the reliability or accuracy of the data provided by third parties. Securities lending data correct as at date not available. Charge data correct as at date not available. Holdings correct as at 31 October 2024. News service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2024. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.